These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6693665)

  • 61. The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment.
    Busse WW; Smith A; Bush RK
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):577-82. PubMed ID: 3771949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma].
    Ukena D; Harnest U; Sakalauskas R; Magyar P; Vetter N; Steffen H; Leichtl S; Rathgeb F; Keller A; Steinijans VW
    Pneumologie; 1998 Jul; 52(7):377-84. PubMed ID: 9738388
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.
    Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX
    Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
    Newnham DM; Grove A; McDevitt DG; Lipworth BJ
    Thorax; 1995 May; 50(5):497-504. PubMed ID: 7597661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
    Rossi A; Kristufek P; Levine BE; Thomson MH; Till D; Kottakis J; Della Cioppa G;
    Chest; 2002 Apr; 121(4):1058-69. PubMed ID: 11948033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
    Peters SP; Prenner BM; Mezzanotte WS; Martin P; O'Brien CD
    Allergy Asthma Proc; 2008; 29(5):499-516. PubMed ID: 18694544
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma.
    Joad JP; Ahrens RC; Lindgren SD; Weinberger MM
    J Allergy Clin Immunol; 1987 Jan; 79(1):78-85. PubMed ID: 3805550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of a new device (aerochamber) for use with aerosol drugs in asthmatic children.
    Gurwitz D; Levison H; Mindorff C; Reilly P; Worsley G
    Ann Allergy; 1983 Mar; 50(3):166-70. PubMed ID: 6338767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
    Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
    Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Prednisolone-dependent asthma patients--often under-treated in ambulatory care? Results of a retrospective study].
    Förster R
    Z Erkr Atmungsorgane; 1991; 177(1-2):96-102. PubMed ID: 1808860
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
    Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.
    Dutoit JI; Salome CM; Woolcock AJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1174-8. PubMed ID: 3674580
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of sustained-release theophylline in nocturnal asthma.
    Freeman W; Packe GE; Cayton RM
    Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative gastroesophageal reflux and pulmonary function in asthmatic children and normal adults receiving placebo, theophylline, and metaproterenol sulfate therapy.
    Berquist WE; Rachelefsky GS; Rowshan N; Siegel S; Katz R; Welch M
    J Allergy Clin Immunol; 1984 Feb; 73(2):253-8. PubMed ID: 6699308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.